These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 17922593)
1. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Park SY; Kim BH; Kim JH; Lee S; Kang GH Arch Pathol Lab Med; 2007 Oct; 131(10):1561-7. PubMed ID: 17922593 [TBL] [Abstract][Full Text] [Related]
2. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468 [TBL] [Abstract][Full Text] [Related]
3. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591 [TBL] [Abstract][Full Text] [Related]
4. Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. O'Connell FP; Wang HH; Odze RD Arch Pathol Lab Med; 2005 Mar; 129(3):338-47. PubMed ID: 15737028 [TBL] [Abstract][Full Text] [Related]
5. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. Bayrak R; Haltas H; Yenidunya S Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990 [TBL] [Abstract][Full Text] [Related]
6. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. McCluggage WG; Shah R; Connolly LE; McBride HA Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982 [TBL] [Abstract][Full Text] [Related]
7. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung]. Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521 [TBL] [Abstract][Full Text] [Related]
9. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622 [TBL] [Abstract][Full Text] [Related]
10. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Su YC; Hsu YC; Chai CY Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563 [TBL] [Abstract][Full Text] [Related]
11. Utility of tissue-specific transcription factors thyroid transcription factor 1 and Cdx2 in determining the primary site of metastatic adenocarcinomas to the brain. Strickland-Marmol LB; Khoor A; Livingston SK; Rojiani A Arch Pathol Lab Med; 2007 Nov; 131(11):1686-90. PubMed ID: 17979487 [TBL] [Abstract][Full Text] [Related]
12. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin. Tsao SC; Su YC; Wang SL; Chai CY Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426 [TBL] [Abstract][Full Text] [Related]
13. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions. Jang KY; Kang MJ; Lee DG; Chung MJ Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274 [TBL] [Abstract][Full Text] [Related]
14. The utility of the lineage specific immunohistochemical stains SATB2, CDX2, and villin, and the mucin glycoproteins MUC2, MUC5AC, and MUC6 to distinguish pulmonary invasive mucinous adenocarcinoma from metastatic colorectal carcinoma. Rerkpichaisuth V; Lau RP; Meyerson C; Fishbein GA Hum Pathol; 2024 Sep; 151():105627. PubMed ID: 39029534 [TBL] [Abstract][Full Text] [Related]
15. Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Perry A; Parisi JE; Kurtin PJ Hum Pathol; 1997 Aug; 28(8):938-43. PubMed ID: 9269830 [TBL] [Abstract][Full Text] [Related]
16. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases. Malmros K; Lindholm A; Vidarsdottir H; Jirström K; Nodin B; Botling J; Mattsson JSM; Micke P; Planck M; Jönsson M; Staaf J; Brunnström H Virchows Arch; 2024 Aug; 485(2):347-357. PubMed ID: 37349623 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805 [TBL] [Abstract][Full Text] [Related]
19. CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens. Tanaka S; Saito K; Ito T; Tajima K; Mogi A; Shitara Y; Sano T; Kuwano H Oncol Rep; 2007 Jul; 18(1):87-92. PubMed ID: 17549351 [TBL] [Abstract][Full Text] [Related]
20. [CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract]. Yue C; Piao Y; Bai Y; Liu H; Zhang L Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2447-50. PubMed ID: 26711206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]